Related Experiment Videos
A scenario for the future: biotechnology and pharmacogenesis
J L Gueriguian1, Y Y Chiu, D P Gangi
1Food and Drug Administration, Rockville, Maryland.
Bioprocess Technology
|January 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rapid detection of herpes simplex virus by polymerase chain reaction.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi·2001
FDA perspective on peptide formulation and stability issues.
Journal of pharmaceutical sciences·1998
SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Journal of investigational allergology & clinical immunology·1998
Clinical, autoimmune and demographic profile in systemic lupus erythematosus (SLE) patients from southern Brazil.
Journal of investigational allergology & clinical immunology·1997
Genetic stability of rDNA production systems, a case report.
Developments in biological standardization·1994
Regulatory concerns for the chemistry, manufacturing, and controls of oligonucleotide therapeutics for use in clinical studies.
Antisense research and development·1993
Design, formulation, and optimization of media.
Bioprocess technology·1995
Cell adhesion in animal cell culture: physiological and fluid-mechanical implications.
Bioprocess technology·1995
Microbial biofilms and biofilm reactors.
Bioprocess technology·1995
Cell aggregation and sedimentation.
Bioprocess technology·1995
Transcripts and Protein Expression of Different HMW Non-Myofibrillar Tpm1 Isoforms in Human iPSC-CMs During Differentiation.
Cytoskeleton (Hoboken, N.J.)·2026
Inhibition of Moesin and CD44 in stem cell-derived neurons affects the pathological genetic signature associated with Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
CHEK2 germline gene variant in a patient with a somatotrophinoma and primary hyperparathyroidism: a novel MEN1-like syndrome?
Endocrine oncology (Bristol, England)·2026
Redefining cardiometabolic biomarkers in the big data era: toward a personalized medicine-centered reconstruction of risk prediction models.
Frontiers in cardiovascular medicine·2026
Host Cell Protein Challenges in Antibody Processing: Insights Into Persistence and Mitigation Strategies.
Biotechnology and bioengineering·2026